Professor, University of South Australia
Professor Doug Brooks is a Research Professor in Molecular Medicine who has over 30 years of experience in cell biology, immunochemistry and translational research. Professor Brooks heads the Mechanisms in Cell Biology and Disease Research Concentration in Clinical and Health Sciences at the University of South Australia. Current research objectives include: Developing diagnostic and prognostic biomarkers for prostate and other cancers and characterising the role of innate immunity in viral infections and cancer biology. Professor Brooks is a Director, Chief Scientific Officer and founding member of Envision Sciences Pty. Ltd., which is developing cancer diagnostic, prognostic and imaging technology for clinical practice. Professor Brooks is also a founding member and Director of Viralok Therapeutics, which is developing a PAN-viral therapeutic for respiratory viruses, including the Flu, COVID-19 and the common cold.
RATs for flu exist – should we be self-testing for that too?
Jul 14, 2022 15:30 pm UTC| Health
Flu season has begun uncharacteristically early this year, and so far weve seen around 187,000 laboratory-confirmed cases, 1,323 hospitalisations, and 113 deaths. The risk of infection from either COVID or influenza...
A sustainable future begins at ground level
Canada needs a national strategy for homeless refugee claimants
An eclipse for everyone – how visually impaired students can ‘get a feel for’ eclipses